Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

NCT01455051

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital de la Santa Creu Sant Pau Barcelona, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
  • Institut Catala d'Oncologia L'Hospitalet de Llobregat, Spain
View Trial Details
Completed

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

NCT00951457

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tyrol, Austria
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • A.ö. Landeskrankenhaus Leoben Leoben, Austria
  • Krankenhaus der Elisabethinen Linz Linz, Austria
View Trial Details
Completed

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

NCT01328626

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 52902 Tucson, Arizona, United States
  • Ucsd /Id# 48325 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 48324 Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center /ID# 56810 New York, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02968563

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Ambulante Krebszentrum Schaubstraße Frankfurt (Oder), Brandenburg, Germany
  • Hämatologische-onkologische Gem.-Praxis Dres. Brudler-Heinrich-Bangerter, Augsburg Augsburg, Germany
  • Uniklinik Koln Cologne, Germany
  • Internistische Gemeinschaftspraxis Dres. Schliesser-Käbisch-Weber, Gießen Giessen, Germany
View all 14 locations
View Trial Details

Related conditions